• SENSEX
    NIFTY 50
Business

Aurobindo Pharma stock tumbles, investors wary as Srikakulam API plant gets USFDA warning letter

Updated : June 21, 2019 03:59 PM IST

While the warning letter does not impact the current sales from the facility, it will impact future approvals until remediation steps are complete.
An OAI status is the most severe of three certifications issued to a drug manufacturing plant after a USFDA inspection.
Aurobindo Pharma stock tumbles, investors wary as Srikakulam API plant gets USFDA warning letter

You May Also Like

Live TV
Advertisement